The Absence of Human Equilibrative Nucleoside Transporter 1 Is Associated With Reduced Survival in Patients With Gemcitabine-Treated Pancreas Adenocarcinoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0224
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2004
Authors
Publisher
American Association for Cancer Research (AACR)